Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000179000 | SCV000231188 | likely benign | not specified | 2014-11-15 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000878016 | SCV001020855 | benign | Isolated microphthalmia 5 | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001729430 | SCV002821672 | likely benign | not provided | 2023-03-01 | criteria provided, single submitter | clinical testing | C1QTNF5: BS2; MFRP: BS2 |
Breakthrough Genomics, |
RCV001729430 | SCV005211812 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Clinical Genetics, |
RCV000179000 | SCV001978890 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001729430 | SCV001980653 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Prevention |
RCV004537476 | SCV004741228 | likely benign | MFRP-related disorder | 2019-06-19 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |